Prescriber's Guide - Children and Adolescents, 1st Edition, focuses on psychotropic medications used in younger patients. Stephen M. Stahl presents drug entries addressing therapeutics, age-related dosing, adverse effects, interactions, titration, and monitoring. The reference is intended for clinicians and trainees studying pediatric and adolescent psychopharmacology within the Stahl's Essential Psychopharmacology series.
Digital ebook. No physical book.
Drug-focused entries organize the material around the questions that arise when studying psychopharmacology for children and adolescents. Therapeutic uses are discussed with starting and target doses, adjustment schedules, safety concerns, and interactions. The emphasis is on age-related considerations rather than simply transferring adult medication discussions to younger populations.
Monitoring, switching, and augmentation receive attention alongside side-effect profiles and co-occurring conditions such as ADHD, anxiety, and depression. Consistent entries support comparison between agents and consultation by topic. This first edition is a reference for child mental health clinicians, psychiatrists, and trainees reviewing medication-specific material. These readers can compare therapeutic topics across medications, with safety and monitoring considered alongside intended uses and age-specific prescribing questions.
Stahl's paediatric and adolescent companion takes the familiar drug-entry format and bends it to younger patients, where dosing, safety and monitoring cannot simply be scaled down from adults. Each entry follows the questions a prescriber or trainee would ask: what it treats, where to start, how to titrate, what to watch and when to switch.
The book is medication-centred rather than organized around diagnoses, which lets a reader compare agents on shared dimensions. Therapeutic uses, starting and target doses, adjustment schedules, adverse effects, interactions and monitoring appear in a consistent order, so the reader learns what to look for instead of hunting through prose. Age-related considerations are foregrounded, since children and adolescents raise different questions about metabolism, growth, development and consent. Switching, augmentation and co-occurring conditions such as ADHD, anxiety and depression are discussed alongside the drug profiles. Monitoring is treated as part of prescribing rather than an afterthought. The guide suits clinicians and trainees who want a structured entry point into an agent and a way to weigh one against another.
The organizing premise is that younger patients are not simply smaller adults. Developmental stage, metabolism and safety concerns change how a drug is understood and used. Each entry keeps those differences in view, so the reader does not transplant an adult discussion into a paediatric question.
Entries open with what an agent is used for and how dosing is approached in children and adolescents. Starting and target doses are discussed alongside the therapeutic rationale, so the numbers carry meaning within a clinical context. The reader can see how a use case and a dose schedule belong together.
Adjustment schedules show how treatment is built up or reduced over time rather than set once. Titration is presented as a planned sequence tied to response and tolerability. This makes the entry useful for thinking through a course of treatment, not just its opening prescription.
Side-effect profiles and safety considerations are treated as core content rather than fine print. Monitoring is described as an ongoing responsibility that accompanies prescribing. The discussion aims to help the reader anticipate problems and know what should be followed during treatment.
Potential interactions are covered so that combining agents is considered deliberately. The entry format allows interactions to be read alongside uses and side effects rather than in a separate vacuum. This keeps the reader alert to how one medication may alter the behaviour of another.
The guide moves beyond a single agent to switching, augmentation and the presence of other conditions. Co-occurring ADHD, anxiety and depression are discussed because they shape how treatment is chosen and combined. The reader is helped to think about sequences and combinations, not just isolated prescriptions.
Child and adolescent psychiatrists, mental health clinicians, and trainees or residents studying paediatric psychopharmacology through structured medication profiles.
Edition, audience, and study-guide details at a glance.
Prescriber's Guide - Children and Adolescents, 1st Edition, focuses on psychotropic medications used in younger patients. Stephen M. Stahl presents drug entries addressing therapeutics, age-related dosing, adverse effects, interactions, titration, and monitoring. The reference is intended for clinicians and trainees studying pediatric and adolescent psychopharmacology within the Stahl's Essential Psychopharmacology series.
This listing is for the 1st edition. Check the title, ISBN, and book details above before ordering, especially if your course or reading list names a specific edition.
Child and adolescent psychiatrists, mental health clinicians, and trainees or residents studying paediatric psychopharmacology through structured medication profiles.
Yes. This page includes an original study guide with six thematic sections, key takeaways, and a topic map for structured reading.
More books from this subject area.
